Safety of systemic chemotherapy in a patient with mitochondrial myopathy and non-small-cell lung cancer.
European Institute of Oncology, Milan, Italy.
Chiara
C
Catania
Gianluca
G
Spitaleri
Angelo
A
Delmonte
Monica
M
Giovannini
Francesca
F
Toffalorio
Cristina
C
Noberasco
Nereo
N
Bresolin
Giacomo
G
Comi
Tommaso
T
De Pas
D000230:Adenocarcinoma / Q000150:complications* / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage*; D005971:Glutamates / Q000008:administration & dosage*; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017240:Mitochondrial Myopathies / Q000150:complications*; D000068437:Pemetrexed
D005971:Glutamates; D000068437:Pemetrexed; D006147:Guanine; D016190:Carboplatin